• Laurent DECORY

Pharma and MedTech: creating the commercial re-start plan

Updated: May 24, 2020

Despite dramatic impact during Covid19 outbreak, Pharma and MedTech are expected to be relatively protected on the long run, particularly versus transportation or oil industries. However, the commercial re-start will require significant adaptations to an environment that looks dramatically different. Now is the time to create a re-start plan. Top priorities should include defining a detailed relaunch map, reviving demand and capture pockets of profitable growth should be among top priorities. Helping Pharma and MedTech build a re-start plan and adapted GoToMarket is one the specialties of BlueJet Consulting. Contact us now for a free diagnosis. #postcovid19 Continue reading


1 view0 comments